CFO Jordan Scott purchases 300,000 ZOM shares at $0.06; 7 other insiders buy within 14 days amid -44.4% decline from 52-week high
Jordan Scott, Chief Financial Officer of Zomedica, purchased 300,000 shares at $0.06 on 2025-03-17, establishing his first position in the stock with a total investment of $18,600.00. This transaction coincides with a cluster pattern in which 7 other insiders also bought within the past 14 days, suggesting coordinated confidence at depressed price levels. The stock is currently trading at $0.10, down -44.4% from its 52-week high of $0.18, while the company generated $7.0M in quarterly revenue against a $-6.7M net loss and trades at a $98.0M market cap. The clustering of CFO-level insider purchases during a significant drawdown—combined with positive 8.3% annual revenue growth despite current unprofitability—warrants close investor attention to whether management views the decline as an opportunity or signals underlying business deterioration masked in recent quarterly metrics.